BDBM50101628 2-Amino-1-[3-(benzylamino-methyl)-3,4-dihydro-1H-isoquinolin-2-yl]-3-(4-hydroxy-2,6-dimethyl-phenyl)-propan-1-one::CHEMBL77001
SMILES: Cc1cc(O)cc(C)c1C[C@H](N)C(=O)N1Cc2ccccc2C[C@H]1CNCc1ccccc1
InChI Key: InChIKey=ZXCCLWMAQYTFDD-IGKIAQTJSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Delta-type opioid receptor (Homo sapiens (Human)) | BDBM50101628 (2-Amino-1-[3-(benzylamino-methyl)-3,4-dihydro-1H-i...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 0.920 | n/a | n/a | n/a | n/a |
AstraZeneca R&D Montreal Curated by ChEMBL | Assay Description Agonist potency using GTP-gamma [35S]- binding assay for delta-opioid receptor | J Med Chem 44: 2387-90 (2001) BindingDB Entry DOI: 10.7270/Q25B01RW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Delta-type opioid receptor (Homo sapiens (Human)) | BDBM50101628 (2-Amino-1-[3-(benzylamino-methyl)-3,4-dihydro-1H-i...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 0.410 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Montreal Curated by ChEMBL | Assay Description Binding affinity at cloned human delta-opioid receptor | J Med Chem 44: 2387-90 (2001) BindingDB Entry DOI: 10.7270/Q25B01RW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM50101628 (2-Amino-1-[3-(benzylamino-methyl)-3,4-dihydro-1H-i...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 0.650 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Montreal Curated by ChEMBL | Assay Description Agonist potency using GTP-gamma [35S]- binding assay for mu-opioid receptor | J Med Chem 44: 2387-90 (2001) BindingDB Entry DOI: 10.7270/Q25B01RW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Mu-type opioid receptor (Homo sapiens (Human)) | BDBM50101628 (2-Amino-1-[3-(benzylamino-methyl)-3,4-dihydro-1H-i...) | PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 37 | n/a | n/a | n/a | n/a |
AstraZeneca R&D Montreal Curated by ChEMBL | Assay Description Agonist potency using GTP-gamma [35S]- binding assay for mu-opioid receptor | J Med Chem 44: 2387-90 (2001) BindingDB Entry DOI: 10.7270/Q25B01RW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM50101628 (2-Amino-1-[3-(benzylamino-methyl)-3,4-dihydro-1H-i...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 1.5 | n/a | n/a | n/a | n/a | n/a | n/a |
AstraZeneca R&D Montreal Curated by ChEMBL | Assay Description Agonist potency using GTP-gamma [35S]- binding assay for opioid receptor kappa 1 | J Med Chem 44: 2387-90 (2001) BindingDB Entry DOI: 10.7270/Q25B01RW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Kappa-type opioid receptor (Homo sapiens (Human)) | BDBM50101628 (2-Amino-1-[3-(benzylamino-methyl)-3,4-dihydro-1H-i...) | PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | n/a | n/a | 6.80 | n/a | n/a | n/a | n/a |
AstraZeneca R&D Montreal Curated by ChEMBL | Assay Description Agonist potency using GTP-gamma [35S]- binding assay for opioid receptor kappa 1 | J Med Chem 44: 2387-90 (2001) BindingDB Entry DOI: 10.7270/Q25B01RW | |||||||||||
More data for this Ligand-Target Pair |